BAYTRIL 150 mg δισκία για γάτες και σκύλους
BAYTRIL 150 mg δισκία για γάτες και σκύλους
Authorised
- Enrofloxacin
Product identification
Medicine name:
BAYTRIL 150 mg δισκία για γάτες και σκύλους
Active substance:
- Enrofloxacin
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Enrofloxacin150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma + Veterinär Produkte GmbH
- Provet S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 2780/13-01-2011/K-0051706
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 4/09/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 4/09/2025
